To hear about similar clinical trials, please enter your email below
Trial Title:
Gynecology Beyond Gender: Cervical Cancer Screening in Transgender Men in France
NCT ID:
NCT05924217
Condition:
Cervical Cancer
Transgender Persons
Health Services for Transgender Persons
Conditions: Official terms:
Uterine Cervical Neoplasms
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
Survey questionnaire
Description:
This survey aims to explore the perception that transgender men have of cervical cancer
screening and to identify the challenges they face, the obstacles and the levers to
access this prevention program.
Summary:
In France, cervical cancer screening is the subject of a national screening programme
organized for all asymptomatic individuals aged 25 to 65 years with a cervix. The latter
contributes greatly to the prevention and early treatment of this disease, whose public
health challenge is recognized worldwide.
One of the objectives of this programme is to reduce inequalities in access. Transgender
men, i.e. individuals assigned to the female gender at birth but identifying with the
male gender, are concerned by this screening as long as they still have a cervix,
according to the same modalities as for cisgender women.
However, they are often excluded from health care, including organized screening
programs. Gender change in civil status is one of the obstacles.
The provision of gynaecological care is sometimes inadequate. The lack of knowledge of
health professionals and the problems of discrimination that transgender people may face
reduce the chances of having equitable access.
This survey aims to explore the perception that transgender men have of cervical cancer
screening and to identify the challenges they face, the obstacles and the levers to
access this prevention program.
Criteria for eligibility:
Study pop:
Transgender men, i.e. individuals assigned the female gender at birth but identifying
with the male gender, who retained the cervix
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- transgender male (assigned female at birth but identifying as male)
- aged 25 to 65 years
- Having retained her cervix
- Having had sex before.
Exclusion Criteria:
- Under 25 and over 65
- Not having retained his cervix
- History of cancerous lesion of the cervix
Gender:
Female
Minimum age:
25 Years
Maximum age:
65 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
CHU de Nîmes
Address:
City:
Nîmes
Zip:
30900
Country:
France
Status:
Recruiting
Contact:
Last name:
Ingrid JULIER, Dr.
Phone:
04.66.68.33.21
Email:
ingrid.julier@chu-nimes.fr
Investigator:
Last name:
Ingrid JULIER, Dr.
Email:
Principal Investigator
Start date:
January 2, 2024
Completion date:
December 31, 2024
Lead sponsor:
Agency:
Centre Hospitalier Universitaire de Nīmes
Agency class:
Other
Source:
Centre Hospitalier Universitaire de Nīmes
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05924217
